{
    "Symbol": "LLY",
    "AssetType": "Common Stock",
    "Name": "Eli Lilly and Company",
    "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.",
    "CIK": "59478",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "749533135000",
    "EBITDA": "13373700000",
    "PERatio": "123.14",
    "PEGRatio": "1.431",
    "BookValue": "14.23",
    "DividendPerShare": "4.69",
    "DividendYield": "0.0065",
    "EPS": "6.76",
    "RevenuePerShareTTM": "39.92",
    "ProfitMargin": "0.171",
    "OperatingMarginTTM": "0.312",
    "ReturnOnAssetsTTM": "0.126",
    "ReturnOnEquityTTM": "0.507",
    "RevenueTTM": "35932099000",
    "GrossProfitTTM": "21911600000",
    "DilutedEPSTTM": "6.76",
    "QuarterlyEarningsGrowthYOY": "0.664",
    "QuarterlyRevenueGrowthYOY": "0.26",
    "AnalystTargetPrice": "926.31",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "14",
    "AnalystRatingHold": "7",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "123.14",
    "ForwardPE": "60.24",
    "PriceToSalesRatioTTM": "20.94",
    "PriceToBookRatio": "66.34",
    "EVToRevenue": "21.6",
    "EVToEBITDA": "86.01",
    "Beta": "0.409",
    "52WeekHigh": "966.1",
    "52WeekLow": "447.24",
    "50DayMovingAverage": "867.03",
    "200DayMovingAverage": "725.89",
    "SharesOutstanding": "900405000",
    "DividendDate": "2024-09-10",
    "ExDividendDate": "2024-08-15"
}